CL2014001281A1 - Metodos para disminuir el dolor articular inducido por el ejercicio en mamiferos no artriticos - Google Patents

Metodos para disminuir el dolor articular inducido por el ejercicio en mamiferos no artriticos

Info

Publication number
CL2014001281A1
CL2014001281A1 CL2014001281A CL2014001281A CL2014001281A1 CL 2014001281 A1 CL2014001281 A1 CL 2014001281A1 CL 2014001281 A CL2014001281 A CL 2014001281A CL 2014001281 A CL2014001281 A CL 2014001281A CL 2014001281 A1 CL2014001281 A1 CL 2014001281A1
Authority
CL
Chile
Prior art keywords
methods
joint pain
induced joint
reduce exercise
arthritic
Prior art date
Application number
CL2014001281A
Other languages
English (en)
Spanish (es)
Inventor
Paul Dijkstra
Francis C Lau
James Lugo
Zainulabedin M Saiyed
Original Assignee
Interhealth Nutraceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interhealth Nutraceuticals Inc filed Critical Interhealth Nutraceuticals Inc
Publication of CL2014001281A1 publication Critical patent/CL2014001281A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CL2014001281A 2013-10-24 2014-05-15 Metodos para disminuir el dolor articular inducido por el ejercicio en mamiferos no artriticos CL2014001281A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361895332P 2013-10-24 2013-10-24

Publications (1)

Publication Number Publication Date
CL2014001281A1 true CL2014001281A1 (es) 2015-10-30

Family

ID=51610711

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014001281A CL2014001281A1 (es) 2013-10-24 2014-05-15 Metodos para disminuir el dolor articular inducido por el ejercicio en mamiferos no artriticos

Country Status (14)

Country Link
US (1) US9066926B2 (enExample)
KR (1) KR101664290B1 (enExample)
AR (1) AR095104A1 (enExample)
AU (1) AU2014202041B8 (enExample)
BR (1) BR112014011741A2 (enExample)
CA (1) CA2846644C (enExample)
CL (1) CL2014001281A1 (enExample)
CO (1) CO7020846A2 (enExample)
IN (1) IN2014DE00193A (enExample)
MX (1) MX347669B (enExample)
MY (1) MY180106A (enExample)
PH (1) PH12014501453A1 (enExample)
SG (1) SG11201403524RA (enExample)
WO (1) WO2015060888A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10226513B2 (en) 2015-01-09 2019-03-12 Mark Terrell Smith Method and composition to prevent or improve symptoms of musculoskeletal distress degeneration
US20180078768A1 (en) * 2016-09-16 2018-03-22 Boston Scientific Neuromodulation Corporation Method and apparatus for pain management using heart sounds
US10610688B2 (en) 2016-09-27 2020-04-07 Boston Scientific Neuromodulation Corporation Systems and methods for closed-loop pain management
AU2017335497B2 (en) 2016-09-27 2020-01-16 Boston Scientific Neuromodulation Corporation System for pain management using objective pain measure
US11793217B1 (en) 2016-10-04 2023-10-24 Lonza Greenwood Llc Method of manufacture and pasteurization of products containing undenatured collagen
EP3526007A4 (en) 2016-10-12 2020-05-27 Advanced Biomatrix, Inc. THREE-DIMENSIONAL (3-D) PRINTING INKS MANUFACTURED FROM NATURAL EXTRACELLULAR MATRIX MOLECULES
EP3532155B1 (en) 2016-10-25 2025-08-27 Boston Scientific Neuromodulation Corporation System for pain management using baroreflex sensitivity
WO2018132529A1 (en) 2017-01-11 2018-07-19 Boston Scientific Neuromodulation Corporation Pain management based on brain activity monitoring
US11089997B2 (en) 2017-01-11 2021-08-17 Boston Scientific Neuromodulation Corporation Patient-specific calibration of pain quantification
US10631776B2 (en) 2017-01-11 2020-04-28 Boston Scientific Neuromodulation Corporation Pain management based on respiration-mediated heart rates
US10631777B2 (en) 2017-01-11 2020-04-28 Boston Scientific Neuromodulation Corporation Pain management based on functional measurements
US10729905B2 (en) 2017-01-11 2020-08-04 Boston Scientific Neuromodulation Corporation Pain management based on muscle tension measurements
WO2018132535A1 (en) 2017-01-11 2018-07-19 Boston Scientific Neuromodulation Corporation Pain management based on emotional expression measurements
US10960210B2 (en) 2017-02-10 2021-03-30 Boston Scientific Neuromodulation Corporation Method and apparatus for pain management with sleep detection
CN106713191B (zh) * 2017-02-28 2020-09-08 西安电子科技大学 一种多级搜索sage方法
CN107048412A (zh) * 2017-04-26 2017-08-18 北京盛美诺生物技术有限公司 一种含有ⅱ型胶原蛋白的咀嚼型产品
AU2018304079B2 (en) 2017-07-18 2020-12-03 Boston Scientific Neuromodulation Corporation Sensor-based pain management systems and methods
CN111163797A (zh) * 2017-08-21 2020-05-15 伦萨有限责任公司 组合物和由其制备的营养补剂
CN111093770A (zh) * 2017-08-31 2020-05-01 伦萨有限责任公司 健康促进组合物和使用补剂方法的相关应用
IT201700111939A1 (it) * 2017-10-05 2019-04-05 Jointherapeutics S R L Composizione farmaceutica per l’uso nel trattamento di stati infiammatori
WO2020018504A1 (en) * 2018-07-16 2020-01-23 Lonza Inc. Collagen and cell matter supplement and method for administering same
WO2021016665A1 (en) * 2019-07-30 2021-02-04 Atp Institute Pty Ltd A gummy composition
US20220331406A1 (en) * 2019-09-30 2022-10-20 Lonza Consumer Health Inc. Cannabinoid Product for Improving Musculoskeletal Health
US20230248808A1 (en) * 2020-01-29 2023-08-10 Lonza Greenwood Llc Joint Health Composition and Use Thereof in Healthy Mammals
WO2021178291A1 (en) 2020-03-03 2021-09-10 Lonza Consumer Health Inc. Undenatured type ii collagen in food and beverage applications and uses thereof
JP2023518688A (ja) 2020-03-24 2023-05-08 ロンザ・グリーンウッド・エルエルシー 動物用食品およびおやつにおける非変性ｉｉ型コラーゲン
WO2021252612A1 (en) * 2020-06-12 2021-12-16 Lonza Consumer Health Inc. Undenatured type ii collagen as a supplement for improved endurance, lipid metabolism, and oxidative stress
WO2022040026A1 (en) * 2020-08-19 2022-02-24 Lonza Consumer Health Inc. Method for improving inflammation, joint health, joint mobility, and joint comfort in healthy mammals
CN115120618B (zh) * 2021-03-23 2024-01-26 安徽盛美诺生物技术有限公司 具有改善免疫应答作用的软骨提取物、其制备方法及其用途
CN118215494A (zh) * 2021-11-12 2024-06-18 龙沙格林伍德有限公司 用于治疗骨骼关节的方法以及其组合物和用途
KR102771944B1 (ko) * 2023-09-25 2025-02-26 (주)온오퍼 고함량 액티브 성분을 갖는 반려동물용 츄 형태 영양제

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
EP0565678A1 (en) 1991-11-08 1993-10-20 LOFGREN NISSER, Gunilla Partially occluded contact lens for treating visual and/or brain disorder
US5529786A (en) 1994-02-28 1996-06-25 Moore; Eugene R. Process and product for treatment of rheumatoid arthritis
US5637321A (en) 1994-02-28 1997-06-10 Moore; Eugene R. Method for preparing animal tissue for use in alleviating the symptoms of arthritis in mammals
US5645851A (en) 1994-02-28 1997-07-08 Moore; Eugene R. Product for alleviating the symptons of arthritis in mammals
US6162787A (en) * 1999-04-02 2000-12-19 Immudyne, Inc. Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
US6372794B1 (en) * 1999-08-26 2002-04-16 Marcel E. Nimni Method for alleviating arthritis in mammals
US20020086070A1 (en) 2000-03-11 2002-07-04 Kuhrts Eric Hauser Anti-inflammatory and connective tissue repair formulations
US7083820B2 (en) 2000-09-29 2006-08-01 Schilling Marvin L Method for producing biologically active products
JP2003048850A (ja) 2001-06-01 2003-02-21 Nippon Meat Packers Inc 関節傷害治療剤及び機能性食品
US20060062859A1 (en) * 2004-08-05 2006-03-23 Kenneth Blum Composition and method to optimize and customize nutritional supplement formulations by measuring genetic and metabolomic contributing factors to disease diagnosis, stratification, prognosis, metabolism, and therapeutic outcomes
FR2900155B1 (fr) * 2006-04-21 2008-06-27 Diana Naturals Sa Hydrolisat de cartilage aviaire, procede d'obtention et utilisations
US20100215731A1 (en) 2009-02-20 2010-08-26 Maastricht University Method for improving cartilage repair and/or preventing cartilage degeneration in a joint
US20110218151A1 (en) * 2010-03-04 2011-09-08 Joar Opheim Substances for promoting healthy joint function comprising omega-3 polyunsaturated fatty acids or drivatives thereof, undenatured type ii collagen and, optionally, glucosamine sulfate
CN101822684B (zh) 2010-05-27 2012-08-15 江苏江山制药有限公司 用于防治骨关节痛的复方组合制剂及其制备方法
US20120294898A1 (en) 2011-05-19 2012-11-22 Warsaw Orthopedic, Inc. Injectable dbm for soft tissue repair
CN102423487B (zh) 2011-12-23 2014-04-16 内蒙古伊利实业集团股份有限公司 一种骨关节保健组合物及其应用
CN103203012A (zh) 2012-01-12 2013-07-17 深圳市麦金利实业有限公司 关节保健品

Also Published As

Publication number Publication date
AU2014202041B8 (en) 2020-04-02
US9066926B2 (en) 2015-06-30
KR101664290B1 (ko) 2016-10-11
WO2015060888A1 (en) 2015-04-30
MY180106A (en) 2020-11-23
US20150119335A1 (en) 2015-04-30
AR095104A1 (es) 2015-09-30
CA2846644A1 (en) 2015-07-13
AU2014202041B2 (en) 2019-11-28
MX2014002934A (es) 2015-09-21
CA2846644C (en) 2018-05-01
CO7020846A2 (es) 2014-08-11
BR112014011741A2 (pt) 2017-05-30
PH12014501453B1 (en) 2015-01-21
PH12014501453A1 (en) 2015-01-21
SG11201403524RA (en) 2015-05-28
MX347669B (es) 2017-05-08
AU2014202041A1 (en) 2015-05-14
KR20150059132A (ko) 2015-05-29
IN2014DE00193A (enExample) 2015-05-01

Similar Documents

Publication Publication Date Title
CL2014001281A1 (es) Metodos para disminuir el dolor articular inducido por el ejercicio en mamiferos no artriticos
CR20140376A (es) Compuestos para tratar la atrofia muscular espinal
CL2015002724A1 (es) Métodos para tratar la enfermedad de crohn utilizando un anticuerpo anti-il23
UY35787A (es) Composiciones útiles para tratar trastornos relacionados con kit
EA201590993A1 (ru) Гетеродимерные иммуноглобулины
UY34406A (es) Compuestos y métodos para mejorar la respuesta inmune innata
UY34347A (es) Proteínas de función dual para tratar trastornos metabólicos
UY34740A (es) Atomizador con agentes codificadores
CL2014003017A1 (es) Uso de un heparinoide interactuando con pf4 para tratar efecto mielodepresivo
UY34726A (es) Proceso de montaje de tanques y dispositivos para realizarlo
FI20165044A7 (fi) Energiansyöttö alukselle
UY33909A (es) Metodo para producir fibra de lignina
CO7020877A2 (es) Anticuerpos anti-asic1 y usos de los mismos
BR112016017112A2 (pt) Composições de apilimod e métodos de uso das mesmas
BR112015028066A2 (pt) embarcação com plataforma de popa
UY34355A (es) Composición ecológica para curtido
EP2975408A4 (en) assay kit
DK3788696T3 (da) Turbine med to transformere
EP3833625C0 (en) IMPROVEMENTS IN OR RELATING TO STAIR LIFTS
CL2020002268A1 (es) Métodos para mejorar el rendimiento en rumiantes
BR112015019998A2 (pt) cartucho para utilização em dispositivos de purificação de água
UY34312A (es) Compuesto de benzotiazolona
CL2015002666A1 (es) Formas de dosificación sólidas de antiemético de liberación prolongada
MX2016005473A (es) Metodos y composiciones para mejorar la funcion renal.
UY34235A (es) Instrumento para insertar un supositorio